医療装置ならびに医療産業

市場、技術レポート


●InteLab Corporation

Worldwide Markets and Emerging Technologies for Point-of-Care Testing
「POC(診療現場臨床検査)の世界市場ならびに振興技術」
#IL528
2007年1月発効、価格:$3,795(消費税別)




主要なトピックス
  • 世界の臨床診断市場のトレンドおよびセグメント別市場分析
  • POC検査の発達を促すファクター
  • 病院POC検査市場の分析 - 救命救急診療における検査、ベッドサイド全血血糖モニタリング、迅速(簡易)検査、POC凝血検査、POC心マーカー検査、濫用薬物簡易検査
  • セルフテスティング市場のアセスメント - 全血血糖モニタリング、凝血セルフテスト、妊娠/受胎能力セルフテスト、家庭用感染性疾患テスト、家庭用濫用薬物テスト、家庭用コレステロールテスト
  • 開業医臨床検査市場のセグメント別分析
  • 市場規模ならびに価格傾向の現況と予測、および競争力ファクターの分析
  • 主な商業取引、競合企業の戦略、および技術ポートフォリオの分析
  • 代表的企業30社の詳細なプロフィール




Worldwide Markets and Emerging Technologies for Point-of-Care Testing

Major Topics

  • Trends in the global clinical diagnostics market and market analysis by segment
  • Factors driving growth in point-of-care testing
  • Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests
  • Self-testing market assessment, including whole blood glucose monitoring, coagulation self-testing, pregnancy and fertility testing, home infectious disease and drugs of abuse testing, and home cholesterol testing.
  • Physician’s office laboratory market analysis by segment
  • Current and Forecast Market Size, Pricing Trends, and Analysis of Competitive Factors
  • Key business transactions, competitor strategies, and technology portfolio analysis
  • In-Depth Profiles of 30 Companies


Report published January 2007
Price $3,795

CONTENTS

EXECUTIVE SUMMARY

1.MARKET OVERVIEW
1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
1.2.1 Clinical Chemistry
1.2.2 mmunodiagnostics
1.2.3 Hematology and Coagulation
1.2.4 Microbiology
1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing
1.4 Regulatory Trends Impacting the Use of Point-of-Care Testing
1.5 Cost and Reimbursement Issues in Point-of-Care Testing
1.6 Quality Control and Quality Assurance Issues in Point-of-Care and Alternate Site Testing
1.7 Trends in Self-Monitoring, Wellness Testing, Risk Assessment and Preventative Testing
1.8 Changes in the Site of Health Care Delivery

2.HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS
2.1 Hospital Clinical Testing Environment
2.2 Bedside Critical Care Testing Products Market
2.2.1 Trends in POC Critical Care Test Volume and Equipment Installed Base
2.2.2 Existing POC Critical Care Testing Products
2.2.3 New Technologies Under Development for POC Critical Care Testing
2.2.4 Bedside Critical Care Testing Market Analysis and Forecast
2.2.5 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
2.2.6 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
2.3.2 Existing POC Hemostasis Testing Products
2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market Shares
2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
2.4.3 New Bedside/POC Drugs of Abuse Testing Products Under Development
2.4.4 POC Drugs of Abuse Testing Market Analysis and Forecast
2.4.5 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
2.4.6 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products Market
2.5 POC Cardiac Marker Testing Products Market Analysis
2.5.1 Trends in POC Testing for Cardiovascular Disease
2.5.2 Existing POC Cardiac Marker Products
2.5.3 POC Cardiac Marker Products Under Development
2.5.4 POC Cardiac Marker Market Analysis and Forecast
2.5.5 POC Cardiac Marker Product Suppliers' Sales and Market Shares
2.5.6 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Product Markets
2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
2.6.3 Hospital Bedside Whole Blood Glucose Monitoring Market
2.6.3.1 Products for Hospital Bedside Whole Blood Glucose Monitoring
2.6.3.2 Hospital Bedside Whole Blood Glucose Monitoring Market Analysis
2.6.3.3 Drivers and Limiters of the Hospital Bedside Whole Blood Glucose Monitoring Products Market

''3.HOME AND SELF-TESTING PRODUCTS
3.1 Whole Blood Glucose Self-Testing Products Market''
3.1.1 Existing Whole Blood Glucose Self-Testing Products
3.1.2 Development-Stage Whole Blood Glucose Self-Testing
Products
3.1.2.1 Less Invasive Glucose Testing Devices
3.1.2.2 Implantable Glucose Monitors
3.1.2.3 Noninvasive Glucose Monitoring Products
3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
3.2.1 Trends in Home Pregnancy and Fertility Testing
3.2.2 Existing Products for Home Pregnancy and Fertility Testing
3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
3.3.1 Cholesterol Self-Testing
3.3.2 Fecal Occult Blood Testing
3.3.3 Home Drugs of Abuse Testing
3.3.4 Coagulation Self-Testing
3.3.5 Infectious Disease Self-Testing

4.PHYSICIAN'S OFFICE AND OTHER ALTERNATE SITE TESTING PRODUCTS
4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing POL Products
4.3 New POL Products Under Development
4.4 POL Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets

5.COMPETITOR ASSESSMENT
5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Technology Portfolio Analysis for Leading POC Diagnostics Companies
5.4 Marketing and Distribution Strategies for the Global POC Diagnostics Market

6.COMPANY PROFILES
6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accumetrics
6.4 Adaltis
6.5 Axis-Shield
6.6 Bayer Diagnostics/Siemens
6.7 Beckman Coulter
6.8 BD
6.9 Biosite
6.10 Cepheid
6.11 Cholestech
6.12 Dexcom
6.13 Helena Laboratories.
6.14 Hemocue
6.15 HemoSense
6.16 International Technidyne/Thoratec
6.17 Inverness Medical
6.18 Medtronic Blood Management
6.19 Menarini Diagnostics
6.20 Nanogen
6.21 OraSure Technologies
6.22 Ortho Clinical Diagnostics/LifeScan
6.23 Phamatech
6.24 Princeton BioMeditech
6.25 Qualigen
6.26 Quidel
6.27 Radiometer A/S
6.28 Response Biomedical
6.29 Roche Diagnostics
6.30 Spectral Diagnostics6-57


Appendix Company Listing

InteLab Corporation has served the needs of clients in the medical device and diagnostics industry worldwide since 1991. The company has published market studies covering numerous topics in the medical device and diagnostics industry, and has also performed proprietary market and technology assessments for a wide variety of medical product manufacturers worldwide.




InteLab Corporation は循環器、診断薬、臨床検査装置、外科ならびに整形外科製品等、 幅広い医用装置市場のアナリストで、これまで各社から発売された数多くの 市場レポートを著述しております。当レポートは InteLab Corporationの自主製品です。





お申し込み先:
日本総代理店
株式会社テクトラン
電話:0551-20-5530
FAX: 0551-20-5531
e-mail: info@techtran.co.jp
代表取締役社長:牧野宝留